Anti-FARS2 monoclonal antibody

Pre-made anti-FARS2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FARS2/FARS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2494-Ab-1/ GM-Tg-hg-IP2494-Ab-2Anti-Human FARS2 monoclonal antibodyHuman
GM-Tg-rg-IP2494-Ab-1/ GM-Tg-rg-IP2494-Ab-2Anti-Rat FARS2 monoclonal antibodyRat
GM-Tg-mg-IP2494-Ab-1/ GM-Tg-mg-IP2494-Ab-2Anti-Mouse FARS2 monoclonal antibodyMouse
GM-Tg-cynog-IP2494-Ab-1/ GM-Tg-cynog-IP2494-Ab-2Anti-Cynomolgus/ Rhesus macaque FARS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2494-Ab-1/ GM-Tg-felg-IP2494-Ab-2Anti-Feline FARS2 monoclonal antibodyFeline
GM-Tg-cang-IP2494-Ab-1/ GM-Tg-cang-IP2494-Ab-2Anti-Canine FARS2 monoclonal antibodyCanine
GM-Tg-bovg-IP2494-Ab-1/ GM-Tg-bovg-IP2494-Ab-2Anti-Bovine FARS2 monoclonal antibodyBovine
GM-Tg-equg-IP2494-Ab-1/ GM-Tg-equg-IP2494-Ab-2Anti-Equine FARS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2494-Ab-1/ GM-Tg-hg-IP2494-Ab-2; GM-Tg-rg-IP2494-Ab-1/ GM-Tg-rg-IP2494-Ab-2;
GM-Tg-mg-IP2494-Ab-1/ GM-Tg-mg-IP2494-Ab-2; GM-Tg-cynog-IP2494-Ab-1/ GM-Tg-cynog-IP2494-Ab-2;
GM-Tg-felg-IP2494-Ab-1/ GM-Tg-felg-IP2494-Ab-2; GM-Tg-cang-IP2494-Ab-1/ GM-Tg-cang-IP2494-Ab-2;
GM-Tg-bovg-IP2494-Ab-1/ GM-Tg-bovg-IP2494-Ab-2; GM-Tg-equg-IP2494-Ab-1/ GM-Tg-equg-IP2494-Ab-2
Products NameAnti-FARS2 monoclonal antibody
Formatmab
Target NameFARS2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FARS2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2494-Ag-1Recombinant multi-species SYFM/ FARS2/ COXPD14 protein


    Target information

    Target IDGM-IP2494
    Target NameFARS2
    Gene ID10667,69955,306879,710945,488204,101081296,505390,100050751
    Gene Symbol and SynonymsCOXPD14,FARS1,FARS2,HSPC320,mtPheRS,PheRS,SPG77
    Uniprot AccessionO95363,Q6AYQ3
    Uniprot Entry NameSYFM_HUMAN,SYFM_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000145982
    Target ClassificationN/A

    The target: FARS2, gene name: FARS2, also named as COXPD14, FARS1, HSPC320, PheRS, SPG77. This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.